Value proposition

Global artificial intelligence (AI) medical technology and services company

Eyenuk, Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive BiomarkersTM for risk assessment and disease surveillance. Eyenuk’s first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology for autonomous detection of diabetic retinopathy. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk and Alzheimer’s disease.

Medical image analysis, Consumer vision, Ophthalmic medical devices, Diabetic retinopathy, Telemedicine, Age Related Macular Degeneration, Retinal Diseases, Eye Screening, Macular Degeneration, Glaucoma, Ophthalmology, Optometry, Optical, Cataract, Artificial intelligence, Machine learning, Diabetes, Medical device, Digital health, and Fundus imaging